VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RZB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RZBReinsurance Group of America, Incorporated
$25.34$1.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRZBQuarterly Financials

Reinsurance Group of America, Incorporated (RZB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Reinsurance Group of America, Incorporated (RZB) quarterly income statement — complete revenue, gross profit & net income history

RZB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue6.49M6.64B6.2B5.6B5.23B5.28B5.65B4.88B6.34B5.01B5.17B4.19B4.25B4.38B4.05B3.89B3.93B4.36B4.04B4.13B
Revenue Growth %-99.88%25.8%9.77%14.78%-17.42%5.35%9.22%16.5%49.07%14.42%27.75%7.75%8.2%0.41%0.17%-6.02%-4.61%5.19%10.98%14.67%
Medical Costs & Claims04.77B4.36B4.04B3.82B3.94B4.12B3.71B5.13B3.84B274M275M3.06B1.01B3.05B243M226M253M3.29B240M
Medical Cost Ratio %0%71.91%70.22%72.25%73.04%74.75%72.84%76.1%80.98%76.63%5.3%6.57%72.05%23.06%75.26%6.25%5.75%5.81%81.35%5.8%
Gross Profit01.88B1.85B1.57B1.41B1.33B1.51B1.18B6.34B5.01B4.9B3.91B4.25B3.37B4.05B3.64B3.7B4.11B4.04B3.9B
Gross Margin %0%28.33%29.78%28.02%26.96%25.25%26.67%24.13%100%100%94.7%93.43%100%76.94%100%93.75%94.25%94.19%100%94.2%
Gross Profit Growth %-100%41.14%22.56%33.3%-77.73%-73.4%-69.24%-69.91%49.07%48.71%20.99%7.38%14.8%-17.98%0.17%-6.47%-5.17%4.69%10.98%13.96%
Operating Expenses01.37B1.53B1.23B1.04B1.11B1.29B908M971M46M622M624M825M644M1.06B636M581M659M786M579M
OpEx / Revenue %0%20.64%24.62%21.93%19.91%20.99%22.88%18.61%15.32%0.92%12.02%14.9%19.41%14.72%26.07%16.37%14.79%15.12%19.44%14%
Depreciation & Amortization00000437M000389M000375M000680M00
Combined Ratio %0%92.56%94.84%94.18%92.95%95.73%95.72%94.71%96.31%77.55%17.32%21.47%91.46%37.77%101.33%22.62%20.54%20.93%100.79%19.81%
Operating Income0510M6.2B341M369M225M214M269M6.34B4.96B452M328M4.25B436M4.05B191M310M59M4.04B527M
Operating Margin %0%7.69%100.02%6.09%7.05%4.27%3.79%5.51%100%99.08%8.74%7.83%100%9.96%100%4.92%7.89%1.35%100%12.74%
Operating Income Growth %-100%126.67%2799.07%26.77%-94.18%-95.46%-52.65%-17.99%49.07%1037.84%-88.84%71.73%1271.29%638.98%0.17%-63.76%32.48%-72.69%10.98%118.67%
EBITDA0-860.46M-18M429M451M662M295M344M343M5.35B452M328M406M811M-28M297M-18M739M8M525M
EBITDA Margin %0%-12.97%-0.29%7.66%8.62%12.55%5.22%7.05%5.41%106.85%8.74%7.83%9.55%18.53%-0.69%7.64%-0.46%16.96%0.2%12.7%
Interest Expense99K98M98M88M82M88M81M75M71M69M72M63M53M56M49M42M42M1M41M43M
Non-Operating Income0-112M-96M-88M-82M-88M-81M-75M-71M4.96B4.7B3.83B4.25B-1.02B4.05B1M-42M-692M4.04B3.61B
Pretax Income441K510M320M341M369M225M214M269M272M164M380M265M351M271M-77M254M-60M57M-34M482M
Pretax Margin %6.79%7.69%5.16%6.09%7.05%4.27%3.79%5.51%4.29%3.28%7.34%6.33%8.26%6.19%-1.9%6.54%-1.53%1.31%-0.84%11.66%
Income Tax110K45M65M160M81M75M56M65M60M4M91M58M98M65M-2M55M3M-99M-12M138M
Effective Tax Rate %24.94%8.82%20.31%46.92%21.95%33.33%26.17%24.16%22.06%2.44%23.95%21.89%27.92%23.99%2.6%21.65%-5%-173.68%35.29%28.63%
Net Income331K463M253M180M286M150K156M203M210M158M287M205M252M204M-76M198M-63M156M-22M344M
Net Margin %5.1%6.98%4.08%3.21%5.47%0%2.76%4.16%3.31%3.16%5.55%4.9%5.93%4.66%-1.88%5.1%-1.6%3.58%-0.54%8.32%
Net Income Growth %-99.88%308566.67%62.18%-11.33%36.19%-99.91%-45.64%-0.98%-16.67%-22.55%477.63%3.54%500%30.77%-245.45%-42.44%-145.32%18.18%-110.33%117.72%
EPS (Diluted)0.006.923.782.704.272.212.333.033.132.374.283.013.713.014.182.91-0.942.30-0.324.99
EPS Growth %-100%213.12%62.23%-10.89%36.42%-6.75%-45.56%0.66%-15.63%-21.26%2.39%3.44%494.68%30.87%1406.25%-41.68%-146.08%19.17%-110.22%102.02%
EPS (Basic)0.007.063.832.724.332.252.363.083.182.404.353.063.723.064.242.96-0.942.32-0.325.06
Diluted Shares Outstanding067M67M67M67M66.98M67M67M67M66.72M67M68M68M67.79M68M68M67M67.93M68M69M